The evidence leans constructive7 supporting, 1 against, 1 worth knowing
Supporting
trading 54% above its 200-day average
sitting at 96% of its 52-week range, with little overhead supply from trapped buyers
up 117% over twelve months
matches closing in on a 52-week high, which has beaten the market by +0.51 points over 20 sessions across 27,282 past signals
2 of the scans it matches have a positive measured record
4 independent kinds of evidence agree today, which is uncommon
net margin has widened from 15.9% to 16.9% across four quarters
Against
1 of the scans it matches has historically underperformed the market
Worth knowing
RSI at 72 is stretched; strong stocks stay stretched for a long time, so this is a note on entry timing, not on direction
What would change this read: a close below 985, its 200-day average; a failure to hold the top of its 52-week range.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
How it has performed
price return over each window, measured against zero
What the scans say today
5 of 47 matched on 2026-08-21
SENORES matches 5 of the 47 scans today, across 4 different kinds of evidence. Three or more independent families agreeing is uncommon — it is the same test the shortlist on every page uses.
Return on capital uses profit before tax over equity plus borrowings. The textbook version adds finance costs back; those are not tagged reliably in quarterly filings, so this understates the ratio for a heavily borrowed company rather than flattering it. Balance sheets are filed half-yearly, so these can be up to six months behind the profit figures above.
Analyst call filings were typically +0.14pt vs the market over the next 5 sessions (n=3,352) · M&A filings were typically +0.23pt vs the market over the next 5 sessions (n=981) · AGM / EGM filings were typically +0.00pt vs the market over the next 5 sessions (n=4,362)
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
revenue rose in 3 of the last 3 quarters
Going against it
net margin narrowed from 20.9% to 16.9%
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
2026-06-30 · consolidated
180
39
30
6.61
16.9%
Q4 FY26
2026-03-31 · consolidated
175
47
37
7.96
20.9%
Q3 FY26
2025-12-31 · consolidated
175
45
34
7.29
19.2%
Q3 FY25
2024-12-31 · consolidated
103
20
16
5.04
15.9%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average+9.6%
Versus 200-day average+53.6%
Below 52-week high-2.4%
Above 52-week low+124.7%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)72.4
Higher closes in last 52 of 5
Six-month return+95.38%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.